ArticleFrontiers in endocrinology2026
Predicting resection success in giant pituitary adenomas: morphologic determinants and a preoperative multivariate model.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Endoscopic endonasal transcavernous surgery for knosp grade 3-4 growth hormone-secreting pituitary neuroendocrine tumors: surgical outcomes and predictors of biochemical remission.Neurosurgical review · 2026Article
- Clinically informed preoperative risk stratification for MRI-defined non gross-total resection in nonfunctioning pituitary neuroendocrine tumors: a single-center internal validation study.Frontiers in physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Giant pituitary adenomas present significant therapeutic challenges due to their size, complex morphology, and frequent extension into critical neuroanatomical regions. Endoscopic transsphenoidal surgery (ETSS) has become the preferred first-line treatment, yet factors determining resectability remain incompletely defined. This study retrospectively analyzed 60 patients with giant pituitary adenomas treated via ETSS at a tertiary pituitary center to evaluate clinical characteristics, early surgical outcomes, and preoperative determinants of resection. Visual impairment was the most common presenting symptom and improved in 83.7% of patients. Based on early postoperative imaging, total or gross-total resection was achieved in 76.7% of the cohort, and permanent diabetes insipidus occurred in only 3.3%, with no major vascular or neurological complications observed. Larger tumor volume and maximum diameter, multilobulated morphology, cranial extension pattern, and higher Hardy grades were independently associated with limited resection. A multivariate model integrating volumetric, anatomical, and hormonal variables demonstrated moderate predictive accuracy for identifying patients at risk for subtotal resection (AUC = 0.745). These findings highlight the critical role of tumor geometry and extension patterns in determining the feasibility of complete removal and provide a practical framework for preoperative risk stratification. ETSS provides effective early tumor debulking in patients with giant pituitary adenomas; however, longer-term follow-up is required to fully assess the durability of surgical outcomes and disease control. Methods: We retrospectively analyzed 60 consecutive patients with giant pituitary adenomas who underwent endoscopic transsphenoidal surgery (ETSS) at a tertiary pituitary center between 2015 and 2023. Clinical, radiological, hormonal, and surgical variables were collected from medical records. Tumor volume, cranial extension pattern, Hardy and Knosp classifications, and multilobulated morphology were evaluated using preoperative MRI. Surgical outcomes, complications, and postoperative endocrine and visual results were recorded. Predictors of resection extent were assessed using multivariate logistic regression, and a preoperative prediction model was developed and evaluated with ROC analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.